1. Home
  2. CLPR vs MYO Comparison

CLPR vs MYO Comparison

Compare CLPR & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clipper Realty Inc.

CLPR

Clipper Realty Inc.

HOLD

Current Price

$2.74

Market Cap

46.4M

Sector

Real Estate

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.06

Market Cap

44.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLPR
MYO
Founded
2015
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Industrial Specialties
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.4M
44.8M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
CLPR
MYO
Price
$2.74
$1.06
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
38.8K
312.6K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
10.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$109,997,000.00
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
5.82
40814.79
52 Week Low
$2.69
$0.61
52 Week High
$4.61
$1.99

Technical Indicators

Market Signals
Indicator
CLPR
MYO
Relative Strength Index (RSI) 36.11 51.38
Support Level $2.69 $0.90
Resistance Level $2.95 $1.17
Average True Range (ATR) 0.06 0.09
MACD -0.01 0.01
Stochastic Oscillator 20.83 77.07

Price Performance

Historical Comparison
CLPR
MYO

About CLPR Clipper Realty Inc.

Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: